CFO Geoffrey Parker and SVP Earl Douglas sold shares of Allogene Therapeutics, Inc. via SEC disclosure.
1 report, 1 independent
Updated Thu 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
CFO Geoffrey Parker and SVP Earl Douglas sold shares of Allogene Therapeutics, Inc. via SEC disclosure.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
SELL
French organization that promotes the interests of video game developers